August 19, 2024 · Form 4 insider transaction
Korenberg Matthew E bought 24,554 shares of LFCR, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.; Vests on earlier of July 8, 2025 or the date of the annual meeting of stockholders of the Company first held in calendar year 2025 (provided such date is no less than 50 weeks from July 8, 2024).